BR112018007679A2 - método para produzir uma toxina botulínica - Google Patents

método para produzir uma toxina botulínica

Info

Publication number
BR112018007679A2
BR112018007679A2 BR112018007679A BR112018007679A BR112018007679A2 BR 112018007679 A2 BR112018007679 A2 BR 112018007679A2 BR 112018007679 A BR112018007679 A BR 112018007679A BR 112018007679 A BR112018007679 A BR 112018007679A BR 112018007679 A2 BR112018007679 A2 BR 112018007679A2
Authority
BR
Brazil
Prior art keywords
botulinum toxin
precipitate
buffer
ammonium sulfate
hydrochloric acid
Prior art date
Application number
BR112018007679A
Other languages
English (en)
Portuguese (pt)
Inventor
Sei Kim Chung
Sul Hye-Young
Kim Kyoung-Yun
Seob KIM Myung
Original Assignee
Daewoong Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daewoong Co Ltd filed Critical Daewoong Co Ltd
Publication of BR112018007679A2 publication Critical patent/BR112018007679A2/pt

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/362Cation-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/36Selective adsorption, e.g. chromatography characterised by the separation mechanism involving ionic interaction, e.g. ion-exchange, ion-pair, ion-suppression or ion-exclusion
    • B01D15/361Ion-exchange
    • B01D15/363Anion-exchange
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/145Ultrafiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/14Ultrafiltration; Microfiltration
    • B01D61/147Microfiltration
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D61/00Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
    • B01D61/58Multistep processes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/48Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/24Metalloendopeptidases (3.4.24)
    • C12Y304/24069Bontoxilysin (3.4.24.69), i.e. botulinum neurotoxin
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2315/00Details relating to the membrane module operation
    • B01D2315/16Diafiltration

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Water Supply & Treatment (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
BR112018007679A 2015-11-30 2016-11-23 método para produzir uma toxina botulínica BR112018007679A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020150168196A KR101775682B1 (ko) 2015-11-30 2015-11-30 보툴리눔 독소의 제조방법
PCT/KR2016/013506 WO2017095062A1 (en) 2015-11-30 2016-11-23 Method for producing botulinum toxin

Publications (1)

Publication Number Publication Date
BR112018007679A2 true BR112018007679A2 (pt) 2018-11-06

Family

ID=58797138

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112018007679A BR112018007679A2 (pt) 2015-11-30 2016-11-23 método para produzir uma toxina botulínica

Country Status (13)

Country Link
US (1) US10619143B2 (enExample)
EP (1) EP3383889A4 (enExample)
JP (1) JP6574528B2 (enExample)
KR (1) KR101775682B1 (enExample)
CN (1) CN108350043B (enExample)
AR (1) AR107218A1 (enExample)
AU (2) AU2016364597B2 (enExample)
BR (1) BR112018007679A2 (enExample)
CA (1) CA2997698C (enExample)
MX (1) MX2018004650A (enExample)
RU (1) RU2707255C1 (enExample)
TW (1) TWI623549B (enExample)
WO (1) WO2017095062A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8129139B2 (en) 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
JP5951490B2 (ja) * 2009-10-21 2016-07-13 ルバンス セラピュティックス インク.Revance Therapeutics,Inc. 非複合ボツリヌス神経毒素を精製するための方法およびシステム
KR101723168B1 (ko) * 2015-04-28 2017-04-05 주식회사 대웅 보툴리눔 독소의 제조를 위한 배지 조성물
KR102463881B1 (ko) * 2016-10-04 2022-11-07 (주)메디톡스 보툴리눔 독소 함유 용액으로부터 보툴리눔 독소를 분리하는 방법
KR102516203B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 제조방법
KR102516204B1 (ko) * 2019-04-15 2023-03-30 (주)제테마 보툴리눔 독소의 정제방법
EP3962924A1 (en) * 2019-05-03 2022-03-09 Genentech, Inc. Methods of reducing the enzymatic hydrolysis activity rate in a composition obtained from a purification platform
KR102287437B1 (ko) * 2019-08-14 2021-08-09 주식회사 프로톡스 보툴리눔 독소의 제조방법
TW202136286A (zh) * 2019-12-20 2021-10-01 瑞士商葛德瑪控股公司 純化肉毒桿菌毒素的方法
CN112480221A (zh) * 2020-12-02 2021-03-12 湖北省农业科学院畜牧兽医研究所 产气荚膜梭菌毒素抗原浓缩工艺
KR102724651B1 (ko) * 2021-07-08 2024-11-01 주식회사 파마리서치바이오 비-독소 단백질이 제거된 클로스트리디움 보툴리눔 신경독소 단백질의 정제방법
CO2023018742A1 (es) * 2023-12-29 2025-07-07 Lifefactors S A S Proceso de purificación de macromoléculas con etapas de precipitación selectiva, concentración y diálisis combinadas en condiciones constantes de estabilidad con el cual se obtienen formulaciones estables y de alta pureza

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06192296A (ja) 1992-10-28 1994-07-12 Chiba Pref Gov 治療用医薬品としての結晶a型ボツリヌス毒素の製造法。
JPH06199296A (ja) 1992-12-29 1994-07-19 Toyota Motor Corp ガスタービンエンジンを推進力とする水上飛行機
DE19925739A1 (de) * 1999-06-07 2000-12-21 Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh Therapeutikum mit einem Botulinum-Neurotoxin
GB9914743D0 (en) * 1999-06-24 1999-08-25 Knoll Ag Therapeutic agents
KR20030060150A (ko) * 2002-01-07 2003-07-16 (주)메디톡스 클로스트리디움 보툴리눔 a형 독소를 정제하는 방법
US7452697B2 (en) * 2003-09-25 2008-11-18 Allergan, Inc. Chromatographic method and system for purifying a botulinum toxin
CN1930186A (zh) * 2005-03-03 2007-03-14 阿勒根公司 为获得梭菌毒素的梭菌细菌培养基及方法
KR101025617B1 (ko) 2008-02-25 2011-03-30 메덱스젠 주식회사 클로스트리디움 보툴리눔으로부터 보툴리눔 독소를정제하는 방법
KR20090120222A (ko) * 2008-05-19 2009-11-24 (주)메디톡스 식물 유래 성분 함유 배지 및 가요성 폐쇄 용기를 이용하여클로스트리디움 보툴리눔 독소를 생산하는 방법
US8129139B2 (en) * 2009-07-13 2012-03-06 Allergan, Inc. Process for obtaining botulinum neurotoxin
JP2011074025A (ja) * 2009-09-30 2011-04-14 Chemo-Sero-Therapeutic Research Inst ボツリヌス毒素の精製方法
JP5951490B2 (ja) 2009-10-21 2016-07-13 ルバンス セラピュティックス インク.Revance Therapeutics,Inc. 非複合ボツリヌス神経毒素を精製するための方法およびシステム
KR101134146B1 (ko) * 2010-05-31 2012-04-19 메덱스젠 주식회사 국소 근마비 효과를 갖는 비확산형 보툴리눔 독소와 그의 정제방법
UY33452A (es) 2010-06-16 2012-01-31 Bayer Schering Pharma Ag Triazolopiridinas sustituidas
KR101339349B1 (ko) * 2013-08-02 2013-12-09 주식회사 대웅 보툴리눔 독소의 제조방법

Also Published As

Publication number Publication date
CA2997698C (en) 2021-04-20
AU2019201315B2 (en) 2020-10-15
TW201726703A (zh) 2017-08-01
CN108350043A (zh) 2018-07-31
TWI623549B (zh) 2018-05-11
AU2016364597B2 (en) 2019-01-17
MX2018004650A (es) 2018-08-15
US10619143B2 (en) 2020-04-14
RU2707255C1 (ru) 2019-11-25
KR101775682B1 (ko) 2017-09-06
JP6574528B2 (ja) 2019-09-11
WO2017095062A1 (en) 2017-06-08
US20180251741A1 (en) 2018-09-06
AU2019201315A1 (en) 2019-03-21
CA2997698A1 (en) 2017-06-08
KR20170062694A (ko) 2017-06-08
AR107218A1 (es) 2018-04-11
AU2016364597A1 (en) 2018-04-12
EP3383889A1 (en) 2018-10-10
EP3383889A4 (en) 2019-07-17
CN108350043B (zh) 2022-06-14
JP2018533977A (ja) 2018-11-22

Similar Documents

Publication Publication Date Title
BR112018007679A2 (pt) método para produzir uma toxina botulínica
BR112018016944A2 (pt) composições funcionais derivadas de feijão mungo
JP2018533977A5 (enExample)
CY1120410T1 (el) Μεθοδος για την παραγωγη τοξινης αλλαντιασης
AR102366A1 (es) Procesos para recuperar valores de litio de salmueras con contenido de litio
BR112018010639A2 (pt) método de transfecção transitória para produção retroviral.
NZ595765A (en) Isolation and purification of components of whey
BR112013024571A2 (pt) método para a produção de um líquido de açúcar
BR112017003943A2 (pt) método para a produção de líquido de açúcar
BR112015021883A8 (pt) métodos para controle da concentração de microrganismos indesejáveis em uma solução aquosa empregada em um processo de fermentação
CU20190090A7 (es) Método para remoción de impurezas de preparaciones basadas en polisacáridos capsulares bacterianos
RU2019118566A (ru) Способ производства безлактозного молока
MX391214B (es) Sal lactea, metodo para su produccion y productos alimenticios que la contienen.
BR112013024898A2 (pt) método para produzir um açúcar líquido e um produto químico
AR110290A1 (es) Proceso para la producción de un concentrado de cerveza o sidra
BR112019002669A2 (pt) processo para produzir um produto de fórmula infantil e um produto lácteo ácido a partir de leite animal desengordurado, produto de fórmula infantil e produto lácteo ácido
MX2024008995A (es) Sistemas y metodos para la preparacion de productos derivados de vegetales que utilizan tecnicas de osmosis.
HRP20191573T1 (hr) Postupak za enzimsku pripremu proizvoda glukozida i nusproizvoda iz edukta glukozida
BR112017001039A2 (pt) método para extrair proteínas solúveis de biomassa de microalgas
MX2021012522A (es) Metodo de purificacion de la toxina botulinica.
MX2019007242A (es) Tratamiento de un filtrado proveniente de un biorreactor de membrana anaeorobico (anmbr) con el uso de osmosis inversa o nanofiltracion.
Oliveira et al. Natural caprine whey oligosaccharides separated by membrane technology and profile evaluation by capillary electrophoresis
BR112019002528A2 (pt) componentes inovadores para clarificar caldo de cana-de-açúcar em um processo para produzir açúcar cristal ou não refinado
EA201790691A1 (ru) Биореактор для обработки водного флюида(ов) при помощи биомассы
JP2017518057A5 (enExample)

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]